Agarwal Arjun sold ORKA
September 11, 2026 · Form 4 insider transaction
Agarwal Arjun sold 200 shares of Oruka Therapeutics, Inc. at $94.02 per share, a transaction worth $18.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$94.02
Total value
$18.8K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after15,312
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.98 to $94.05, inclusive.